Curofy
First EDition: News for and about the practice of emergency medicine
FDA approves first naloxone nasal spray for opioid overdose; Therapeutic hypothermia after nonshockable-rhythm cardiac arrest; Andexanet reverses anticoagulant effects of factor Xa inhibitors; Continuous no better than interrupted chest compressions; Answers elusive in quest for better chlamydia treatment; Catheter-directed thrombolysis trumps systemic for acute pulmonary embolism; Survivors of out-of-hospital cardiac arrest usually had intact brain function; Procalcitonin assay detects invasive bacterial infection; Out-of-hospital MI survival is best in the Midwest; Modified Valsalva more than doubled conversion rate in supraventricular tachycardia; Off-label prescriptions link to more adverse events
See this content immediately after install